Discover Our Group:

LATEST NEWS

  • 2025 - 05 - 04

    Swiss Biotech Day

    Creating highly productive clonal cell lines for Monoclonal Antibody (mAb) production is time-consuming, labor-intensive, and costly, since achieving consistent cell culture performance requires careful screening, selection, and optimization of media formulations and feed.
  • 2025 - 04 - 18

    ERBC and Menarini Biotech Join Forces to Accelerate the Development of Biopharmaceuticals from Research to First-in-Human Clinical Trials

  • 2025 - 04 - 14

    Doha Forum Montalcini global biotech tour 2025

    Creating highly productive clonal cell lines for Monoclonal Antibody (mAb) production is time-consuming, labor-intensive, and costly, since achieving consistent cell culture performance requires careful screening, selection, and optimization of media formulations and feed.